May 5 (Reuters) - Cytokinetics said on Tuesday its experimental heart disease drug significantly improved symptoms of a genetic heart condition in a late-stage trial. Shares of the company were up 13.
Lifestyle, environment, and genetics can shape heart disease risk, but a new study from UConn researchers explores how ...
It seems like there's scary news about heart health everywhere. On highway billboards, in news alerts about celebrities and ...
Scientists have developed a breakthrough injectable biomaterial that travels through the bloodstream to repair damaged tissue ...
Heather Riley was unknowingly suffering from a serious heart disease ...
You can’t predict when or how you’re going to die, but you may be able to estimate what you’re more likely to die of ...
Pups with poor diet and little exercise are at heightened risk, which is why ensuring they stay active and eat well is ...
Briefly on MSN
Good Hope FM announces death of popular presenter Lorenzo Darries following a battle with heart disease
South African radio presenter Lorenzo Darries has passed away following a battle with heart disease. Good Hope FM announced ...
Less than 1 percent of cancers start in the heart, and disease that begins elsewhere seldom spreads to the blood-pumping ...
Diabetes is a common, chronic (lifelong) condition affecting people of all ages. According to the Centers for Disease Control ...
His current project, “Don’t Pass on Your Heart Health,” is an awareness campaign deeply connected to his experience with an often unrecognized and little-known condition: ATTR-CM.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results